The Oncology Institute, Inc. (NASDAQ:TOIIW) Short Interest Update

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 3,100 shares, a growth of 19.2% from the November 30th total of 2,600 shares. Based on an average daily volume of 43,000 shares, the short-interest ratio is currently 0.1 days.

Oncology Institute Stock Performance

TOIIW stock opened at $0.01 on Tuesday. The company’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.02. Oncology Institute has a 12-month low of $0.01 and a 12-month high of $0.37.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.